Similarly, the transcription factor BHLHE40 reportedly enhances AMPK signaling by downregulating the phosphatase PPM1F, shifting tumor metabolism from glycolysis to oxidative phosphorylation [31]. The gene discussed is PPM1F; the disease is neoplasm.